Literature DB >> 11059876

Radiofrequency ablation in the treatment of hepatocellular carcinoma--a clinical viewpoint.

A Grasso1, A F Watkinson, J M Tibballs, A K Burroughs.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11059876     DOI： 10.1034/j.1600-0641.2000.033004667.x

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

Review 1.  Ablative therapy for liver tumours.

Authors:  E A Dick; S D Taylor-Robinson; H C Thomas; W M W Gedroyc
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.

Authors:  Ming-De Lu; Hui-Xiong Xu; Xiao-Yan Xie; Xiao-Yu Yin; Jun-Wei Chen; Ming Kuang; Zuo-Feng Xu; Guang-Jian Liu; Yan-Lin Zheng
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

3.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Radiofrequency ablation for hepatocellular carcinoma and liver metastases: experience in Hospital La Paz.

Authors:  Silvia Gómez Senent; César Gómez Raposo; Noemi Manceñido Marcos; Sonia Martín Chavarri; Gemma Carrión Alonso; Antonio Olveira Martín; José María Segura Cabral; Manuel González Barón
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

5.  Analgesic efficacy and safety of nalbuphine versus morphine for perioperative tumor ablation: a randomized, controlled, multicenter trial.

Authors:  Youhua Xue; Zhengli Huang; Bingwei Cheng; Jie Sun; Haidong Zhu; Yuting Tang; Xiaoyan Wang
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

Review 6.  Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors.

Authors:  Hyeon Yu; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.